The Weal and Woe of Costimulation in the Adoptive Therapy of Cancer with Chimeric Antigen Receptor (CAR)-Redirected T Cells

Publisher： Bentham Science Publishers

E-ISSN： 1875-5666|13|7|1079-1088

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.13, Iss.7, 2013-08, pp. : 1079-1088

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chimeric antigen receptor-redirected T cells display multifunctional capacity and enhanced tumor-specific cytokine secretion upon secondary ligation of chimeric receptor

By Henderson Melissa A Yong Carmen SM Duong Connie PM Davenport Alexander J John Liza B Devaud Christel Neeson Paul Westwood Jennifer A Darcy Phillip K Kershaw Michael H

Immunotherapy, Vol. 5, Iss. 6, 2013-06 ,pp. : 577-590

Future Medicine

Access to resources Recommend Favorite

Of chimeric antigen receptors and antibodies: OX40 and 41BB costimulation sharpen up T cell-based immunotherapy of cancer

By Hombach Andreas A Abken Hinrich

Immunotherapy, Vol. 5, Iss. 7, 2013-07 ,pp. : 677-681

Future Medicine

Access to resources Recommend Favorite

BAFF production by antigen‐presenting cells provides T cell co‐stimulation

By Huard Bertrand

International Immunology, Vol. 16, Iss. 3, 2004-03 ,pp. : 467-475

Oxford University Press

Access to resources Recommend Favorite

Challenges of creating effective chimeric antigen receptors for cancer therapy

By Sentman Charles L

Immunotherapy, Vol. 5, Iss. 8, 2013-08 ,pp. : 783-785

Future Medicine

Access to resources Recommend Favorite

Targeting T cells to tumor: exploiting the chimeric antibody receptor

By Gilham David E Cheadle Eleanor J

Immunotherapy, Vol. 5, Iss. 9, 2013-09 ,pp. : 927-929

Future Medicine

Access to resources Recommend Favorite